An Indian manufacturer's perspective for harmonization of guidelines for similar biotherapeutic products
… This review focuses on the scenario of Indian manufacturers, biotherapeutics approvals in India … hit the Indian market at 85% lower prices that are affordable to the masses in India. The …..... Read More